In the BioHarmony Drug Report Database

"Preview" Icon

Somapacitan-beco

Sogroya (somapacitan) is a small molecule pharmaceutical. Somapacitan was first approved as Sogroya on 2021-03-31. It has been approved in Europe to treat growth.

 

Trade Name

 

Sogroya
 

Common Name

 

somapacitan
 

ChEMBL ID

 

CHEMBL3707290
 

Indication

 

growth
 

Drug Class

 

Growth hormone derivatives

Image (chem structure or protein)

Somapacitan-beco structure rendering